QTRX
Quanterix is a biotechnology company that develops ultrasensitive biomarker detection technology for precision health research and clinical applications. It offers Simoa® digital immunoassay instruments, a broad menu of assay kits, and custom assay development services, enabling researchers to quantify low-abundance proteins across neurology, oncology, cardiology, immunology/inflammation, and infectious disease. Headquartered in Massachusetts with a global footprint, Quanterix focuses on enabling early disease detection, prognosis, and monitoring through highly sensitive biomarker measurements.
No recent news for this company.
No recent deals for this company.